# Marvell Technology, Inc.: filings

MRVL · Nasdaq · CIK 1835632 · [Technology](/sectors/technology.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/mrvl.md) · [Financials](/companies/mrvl/financials.md) · [Filings](/companies/mrvl/filings.md) · [Insiders](/companies/mrvl/insiders.md)

## Reports and events: 116 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 475, 144 129, 8-K 85, 3 28, 10-Q 17, CORRESP 8, DEFA14A 8, SC 13G/A 8, SCHEDULE 13G/A 8, UPLOAD 8, DEF 14A 6, SD 6, 10-K 5, 424B7 5, EFFECT 5, S-8 5, 424B3 4, ARS 4, S-4 4, 424B2 3, 424B5 3, 8-K/A 3, FWP 3, S-4/A 3, SC 13G 3, 425 2, 4/A 2, D 2, 305B2 1, 3/A 1, 8-K12B 1, S-3 1, S-3ASR 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:05 ET | [8-K](/filings/0001193125-26-430424.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-430424 |
| 2026-09-25 | 20:35 ET | [8-K](/filings/0001628280-26-063592.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063592 |
| 2026-08-28 | 20:04 ET | [10-Q](/filings/0001835632-26-000025.md) | Quarterly report, period 2026-08-01 | 0001835632-26-000025 |
| 2026-08-27 | 20:05 ET | [8-K](/filings/0001835632-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001835632-26-000022 |
| 2026-08-19 | 12:25 ET | [8-K](/filings/0001193125-26-356217.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-356217 |
| 2026-07-09 | 21:19 ET | [8-K](/filings/0001193125-26-299843.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-299843 |
| 2026-06-25 | 20:43 ET | [8-K](/filings/0001628280-26-045564.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-045564 |
| 2026-06-11 | 20:33 ET | [8-K](/filings/0001193125-26-267688.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-267688 |
| 2026-05-28 | 20:09 ET | [10-Q](/filings/0001835632-26-000019.md) | Quarterly report, period 2026-05-02 | 0001835632-26-000019 |
| 2026-05-27 | 20:06 ET | [8-K](/filings/0001835632-26-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001835632-26-000014 |
| 2026-05-13 | 20:15 ET | [DEF 14A](/filings/0001104659-26-060253.md) | Proxy statement, period 2026-06-25 | 0001104659-26-060253 |
| 2026-04-15 | 20:35 ET | [8-K](/filings/0001193125-26-157134.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-157134 |
| 2026-03-31 | 20:01 ET | [8-K](/filings/0001193125-26-134462.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-134462 |
| 2026-03-19 | 20:45 ET | [8-K](/filings/0001628280-26-019851.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-019851 |
| 2026-03-19 | 20:10 ET | [8-K](/filings/0001193125-26-115987.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-115987 |
| 2026-03-11 | 20:04 ET | [10-K](/filings/0001835632-26-000011.md) | Annual report, period 2026-01-31 | 0001835632-26-000011 |
| 2026-03-05 | 21:06 ET | [8-K](/filings/0001835632-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001835632-26-000006 |
| 2026-02-18 | 11:05 ET | [8-K](/filings/0001193125-26-055923.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-055923 |
| 2026-02-06 | 11:02 ET | [8-K](/filings/0001193125-26-040202.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-040202 |
| 2026-02-02 | 14:16 ET | [8-K/A](/filings/0001193125-26-032861.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-032861 |
| 2025-12-12 | 21:19 ET | [8-K](/filings/0001628280-25-056774.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-056774 |
| 2025-12-03 | 21:04 ET | [10-Q](/filings/0001835632-25-000197.md) | Quarterly report, period 2025-11-01 | 0001835632-25-000197 |
| 2025-12-02 | 21:15 ET | [8-K](/filings/0001193125-25-305289.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-305289 |
| 2025-12-02 | 21:11 ET | [8-K](/filings/0001835632-25-000193.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001835632-25-000193 |
| 2025-12-02 | 21:11 ET | [8-K](/filings/0001193125-25-305271.md) | 8.01 Other events | 0001193125-25-305271 |
| 2025-09-25 | 19:06 ET | [8-K](/filings/0001193125-25-217311.md) | 8.01 Other events | 0001193125-25-217311 |
| 2025-09-24 | 13:15 ET | [8-K](/filings/0001193125-25-214314.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-214314 |
| 2025-09-19 | 20:15 ET | [8-K](/filings/0001193125-25-209108.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-209108 |
| 2025-08-29 | 20:04 ET | [10-Q](/filings/0001835632-25-000189.md) | Quarterly report, period 2025-08-02 | 0001835632-25-000189 |
| 2025-08-28 | 20:06 ET | [8-K](/filings/0001835632-25-000187.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001835632-25-000187 |
| 2025-08-14 | 13:04 ET | [8-K](/filings/0001193125-25-180425.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-180425 |
| 2025-07-23 | 13:11 ET | [8-K](/filings/0001193125-25-163086.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-163086 |
| 2025-07-17 | 21:00 ET | [8-K](/filings/0001193125-25-160597.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-160597 |
| 2025-06-30 | 20:10 ET | [8-K](/filings/0001193125-25-152676.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-152676 |
| 2025-06-20 | 13:14 ET | [8-K](/filings/0001193125-25-143288.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-143288 |
| 2025-06-13 | 20:15 ET | [8-K](/filings/0001193125-25-140767.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-140767 |
| 2025-05-30 | 20:06 ET | [10-Q](/filings/0001835632-25-000117.md) | Quarterly report, period 2025-05-03 | 0001835632-25-000117 |
| 2025-05-29 | 20:06 ET | [8-K](/filings/0001835632-25-000115.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001835632-25-000115 |
| 2025-05-06 | 21:02 ET | [8-K](/filings/0001193125-25-113881.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-113881 |
| 2025-05-01 | 13:00 ET | [DEF 14A](/filings/0001104659-25-043088.md) | Proxy statement, period 2025-06-13 | 0001104659-25-043088 |
| 2025-04-14 | 13:27 ET | [8-K](/filings/0001193125-25-079772.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-079772 |
| 2025-04-08 | 22:56 ET | [8-K](/filings/0001193125-25-074816.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-074816 |
| 2025-03-21 | 20:21 ET | [8-K](/filings/0001835632-25-000068.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001835632-25-000068 |
| 2025-03-12 | 21:04 ET | [8-K](/filings/0001193125-25-053027.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-053027 |
| 2025-03-12 | 20:05 ET | [10-K](/filings/0001835632-25-000057.md) | Annual report, period 2025-02-01 | 0001835632-25-000057 |
| 2025-03-05 | 21:09 ET | [8-K](/filings/0001835632-25-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001835632-25-000051 |
| 2024-12-13 | 21:33 ET | [8-K](/filings/0001835632-24-000211.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001835632-24-000211 |
| 2024-12-04 | 21:05 ET | [10-Q](/filings/0001835632-24-000200.md) | Quarterly report, period 2024-11-02 | 0001835632-24-000200 |
| 2024-12-03 | 21:06 ET | [8-K](/filings/0001835632-24-000197.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001835632-24-000197 |
| 2024-12-02 | 13:44 ET | [8-K](/filings/0001835632-24-000193.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001835632-24-000193 |

Page 1 of 3. [Older](/companies/mrvl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.